Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry

SiliconANGLEby Duncan RileyOct 22, 3:08 PM PT

Context: Kevin Weil, formerly OpenAI's science lead, is building a chemistry contract research organization; TechCrunch says human chemists will train robots for lab tasks.

From SiliconANGLE: Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S.

Warp Sciences · $215MAs stated by SiliconANGLE.

Source

SiliconANGLE (siliconangle.com)

Published

Oct 22, 3:08 PM PT

First seen here

Oct 23, 8:16 PM PT

Edition

Friday, October 23, 2026, ranked 37

Status

A publication reported this; the company may not have confirmed it.

Topics

AI, Health, Robotics